Brad Franzwa

Brad Franzwa is a professional with extensive experience in grants and contracts management, currently serving as the Grants and Contracts Manager at Perspective Therapeutics since February 2023, following the merger of Isoray and Viewpoint Molecular Targeting. Previous roles include Grants and Contracts Manager and Clinical Trials Manager at Viewpoint Molecular Targeting from April 2021 to April 2023, and Fiscal Director at the Heritage Area Agency on Aging, where oversight of financial systems and budget management was essential. Additionally, Brad spent nearly 27 years at the University of Iowa in various roles, including Clinical Trials Research Manager and Senior Financial Analyst. Brad holds a Bachelor of Business Administration degree in Accounting from Mount Mercy University.